Patient involvement in trial design: looking to the futureCOVID-19 has transformed the way we think about patient participation in trial design – but there are still Share XPatient involvement in trial design: looking to the futurehttps://pharmaphorum.com/patients/patient-involvement-in-trial-design-looking-to-the-future/
Deep Dive: Patients and PartnershipsAs this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – Share XDeep Dive: Patients and Partnershipshttps://pharmaphorum.com/views-analysis-patients/deep-dive-patients-and-partnerships/
3 steps for comprehensive patient collaborationJanssen’s Daniel de Schryver tells us why it’s time to give patients a permanent seat at the table Share X3 steps for comprehensive patient collaborationhttps://pharmaphorum.com/views-analysis-patients/3-steps-for-comprehensive-patient-collaboration/
Increasing patient engagement with UK clinical trialsPharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so Share XIncreasing patient engagement with UK clinical trialshttps://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials/
Are rapid progress and patient engagement mutually exclusive in a COVID-19 world?COVID-19 has sparked a flurry of research and discoveries are being made at an unprecedented rate – but Share XAre rapid progress and patient engagement mutually exclusive in a COVID-19 world?https://pharmaphorum.com/r-d/views-analysis-r-d/are-rapid-progress-and-patient-engagement-mutually-exclusive-in-a-covid-19-world/
Working with, advocating for, and empowering patients – a holistic viewIn recent years, there has been a clear shift in pharma when it comes to how it interacts Share XWorking with, advocating for, and empowering patients – a holistic viewhttps://pharmaphorum.com/views-analysis-patients/working-advocating-empowering-patient-centricity/
The many faces of patient-pharma co-creationAhead of her appearance at eyeforpharma Barcelona, Merck’s director of patient advocacy and strategic partnerships, Vanessa Pott, tells Share XThe many faces of patient-pharma co-creationhttps://pharmaphorum.com/views-analysis-patients/the-many-faces-of-patient-pharma-co-creation-merck-eyeforpharma/
Boosting trial recruitment through patient engagementImproving clinical trial recruitment has long been a priority for pharma, but despite having a plethora of new Share XBoosting trial recruitment through patient engagementhttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/boosting-trial-recruitment-through-patient-engagement-syneos/
A year of building patient centric foundationsIt’s been a year of putting patient centricity theory into practice, as companies and industry organisations alike have Share XA year of building patient centric foundationshttps://pharmaphorum.com/views-analysis-patients/2019-in-review-a-year-of-building-patient-centric-foundations/
